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The notion that alioimmune as well as self-restricted cytotoxic T  lymphocytes 
(CTL) recognize conformational determinants on class I major histocompatibility 
complex (MHC)  molecules rather than primary amino acid (AA)  sequences  is 
based on the following arguments.  First, an increasing body of evidence shows 
that  the  repertoires  of alloimmune and  self-restricted  CTL  overlap  and  thus 
recognize similar target structures on class I MHC molecules (1-3). This finding 
is explained best by assuming that self-restricted CTL recognize antigen-induced 
conformational changes  in  self-class  I  molecules  rather  than  foreign  antigen 
itself (4).  Indeed,  antigen-specific  CTL  can  be  blocked  easier  with  anti-H-2 
antibody than with antibody to the foreign antigen (5, 6), and virus-specific CTL 
are  more  cross-reactive  than  virus-specific  antibody  (6).  Second,  analysis  of 
alloimmune CTL directed against mutant H-2K  b molecules has provided a more 
direct argument for recognition of conformational H-2  determinants by CTL. 
Bulk CTL or CTL clones generated against a  particular H-2K  b mutant cross- 
reacted with other K b mutants bearing unrelated AA substitutions in completely 
different sites of the H-2K  b molecule (4, 7). 
We have now asked whether B6  anti-bml  CTL, exclusively directed against 
antigens created by AA substitutions at positions  152,  155, and  156  of the H- 
2K  b molecule (8,  9), detect the same antigens in the H-2L  d molecule, which is 
structurally identical with the H-2K  bm~ molecule from positions 146-162 (8-1 1), 
thus including all  three  AA  substitutions,  but  differs considerably elsewhere. 
The answer is no, thus providing strong direct evidence for the notion that CTL 
do not recognize primary AA sequences, but conformational determinations on 
class I MHC molecules. 
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Materials and Methods 
Animals.  All mice were bred at the Central Laboratory of the Netherlands Red Cross 
Blood Transfusion Service,  Amsterdam, The Netherlands. 
Generation of Alloimmune CTL.  Responder  spleen  cells  (108) were  cocultured with 
irradiated (2,000 rad) spleen cells (10  a) as stimulator cells in 80 ml of culture medium for 
5 d at 37°C in humidified air with 5% CO2. The culture medium consisted of Iscove's 
modified Dulbecco's medium (IMDM) with  10% pooled human serum, penicillin (100 
IU/ml), streptomycin (100 #g/ml), and 2-mercaptoethanol (2 x  10  -5 M). 
Cell-mediated Lymphocytotoxicity (CML).  Varying numbers of effector cells were added 
to 3 x  104 Na25~CrO4 (~Cr)-Iabeled target cells in 0.2 ml IMDM supplemented with 10% 
fetal calf serum (Gibco Laboratories, Grand Island, NY) in wells of round-bottom micro- 
titer plates and incubated for 4 h at 37 °C in humidified air with 5% CO2. After incubation, 
the supernatant was collected with the Titertek Supernatant Collection System (Flow 
Laboratories, Inc., McLean, VA).  As target cells we used Con A-induced (2.5  ~g/ml) 
lymphoblasts. The percentage of specific 5aCr release was calculated by the formula: 
cpm experimental well -  back~round 5~Cr release 
% specific  lysis =  cpm 5% saponin release -  background ~Cr release x  100. 
Background ~Cr release was taken to be the release in the presence of responder spleen 
cells cocultured with irradiated syngeneic spleen cells. The standard error of triplicate 
cultures was always <3% specific 5~Cr release. 
Adsorption of CTL on spleen-cell monolayers was performed as described before (12). 
Results 
Cross-reactivity of B6 Anti-bm l  CTL Against Target Cells of Various H-2 Haplotypes 
IncludingH-2 u.  B6 (H-2 b) mice are tolerant of all bml structures except for new 
antigens created by the AA substitutions at positions  152,  155, and  156 of the 
H-2K  bm~ molecule (8,  9).  Because the L d molecule is structurally identical with 
the K bml  molecule in the AA positions  146-162  (10,  11),  including AA substi- 
tutions responsible for all antigenic changes in bm 1 against which B6 is allowed 
to react, it was of interest to test whether Ld-bearing target cells were lysed to 
the same extent as bm 1 target cells. The results shown in Fig. 1 indicate that this 
is not the case. Although CTL cross-reactivity against B10.D2  (H-2 d) as well as 
B10.BR  (H-2k),  B10.G (H-2q),  B10.R  III (H-2r),  and B10.M  (H-2 f) target cells 
was apparent,  the level of lysis was much less than against the sensitizing type 
bm 1 target cells. Low and inconsistent levels of cross-kill were observed against 
B10.S (H-2 s) and C3H.NB (H-2 p) targets (Fig.  1). 
L'%earing Monolayers Fail to Adsorb the Activity of B6 Anti-bml  CTL Against bml 
Target Cells.  Because of the structural relationship between K bml and L d referred 
to above, it was of interest to test whether Ld-bearing B 10.D2 monolayers could 
adsorb all CTL activity against bml  target cells. The results represented in Fig. 
2A  show that they failed to do so.  In control experiments, adsorption of anti- 
bml  CTL to bml  monolayers led to strong reduction of CTL activity against 
bml  and to complete elimination of all cross-reactivity against H-2 d, H-2 k, and 
H-2 q target cells (data not shown). Adsorption to B6 monolayers did not influence 
the CTL reaction pattern (data not shown). Thus, a major cell population among 
B6 anti-bml  CTL is uniquely directed against'K  bin1 and cannot be adsorbed to 
Ld-bearing monolayers, even though the reactivity against B10.D2  targets was 
almost completely removed (Fig. 2A). 
Recognition of H-2L u by a Subset of B6 Anti-bml  CTL.  Although the anti-H-2  d 1722  CYTOTOXIC  T  LYMPHOCYTES 
FIGURE  1. 
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B6 anti-bml CTL tested on a panel of target cells. In parentheses, the H-2 
activity of B6 anti-bml  CTL is clearly distinct from a  major CTL population 
uniquely directed against bml,  it was still  of interest to establish whether the 
anti-H-2  d activity is directed against H-2L  d. In direct iysis experiments, dm2 (L  d 
loss  mutant) target cells were lysed to the same extent as B10.D2  target cells 
(data not shown).  Adsorption experiments indicated that  B10.D2  monolayers 
adsorbed  all  CTL  activity  against  both  B10.D2  and  dm2  targets  (Fig.  2A), 
whereas din2  monolayers adsorbed  the  activity against  dm2  but  not  against 
B10.D2 targets (Fig. 2B). Thus, the anti-H-2  d activity is distinct from the unique 
anti-bml  CTL  population  and  can  be  ascribed  to  at  least  two  other  CTL 
populations, one directed against L  d and another directed against H-2  d minus 
L  d" 
Further Identification  of CTL Subpopulations Included in B6 Anti-bml  CTL.  By 
means of monolayer adsorption, additional CTL subpopulations included within 
B6 anti-bm 1 CTL were identified. 
(A) Adsorption with H-2  d did not remove CTL activity against B10.BR (H-2 k) 
(Fig. 2A). This anti-H-2 k population is distinct from the unique anti-bml subset 
because  adsorption  onto  B10.BR  monolayers strongly reduced  CTL  activity 
against  B10.BR  but  not against bml  target cells (Fig.  2C).  As expected,  the 
adsorption onto B10.BR  did not reduce the activity against B10.D2  and dm2 
(Fig. 2C). 
(B) The anti-H-2 k CTL population was shown to consist of at least two subsets. 
One  is  directed against  K  k because  after  absorption  onto  C3H.OH  (K  d  D k) 
monolayers CTL activity against B 10.A (4R) (K  k D  b) and B 10.BR remained (Fig. 
2D). The other is directed against D k because B10.A (4R) monolayers failed to 
remove CTL activity against B 10.BR target ceils (Fig. 2 E). The latter adsorption 
also failed to remove activity against B10.AKM  (KkD  q) targets.  This indicates 
that the anti-H-2  q cross-reaction includes a  D  q component distinct from the H- 
2K  k population (Fig. 2 E). It was not investigated whether the anti-Dq population 
is distinct from the anti-D  k population. | 
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FIGURE 2.  Monolayer  adsorption  of B6  anti-bml  CTL:  (A)  adsorbed  to  BI0.D2  (H-2  d) 
monolayer; (B) adsorbed to dm2 (H-2  din2) monolayer; (C) adsorbed to B10.BR (H-2  k) mono- 
layer;  (D)  adsorbed  to  C3H.OH  (d/k)  monolayer,  and  (E)  adsorbed  to  BI0.A(4R)  (k/b) 
monolayer. In parentheses, the H-2 haplotype or H-2K and -D alleles. 
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Discussion 
B6  anti-bml  CTL  are  exclusively  generated  against  novel  H-2K  antigens 
created by the following three AA substitutions: Glu ~  Ala at position 152, Arg 
Tyr at position  155, and Leu ~  Tyr at position  156 (8, 9). The L d molecule 
shares  the  AA at  these  positions  with  K bm~  in  addition  to all  other  AA  from 
positions 146-162 (8-11). If primary AA sequences are the target structure for 
alloimmune CTL, the H-2L  d molecule, on the basis of its structural  identity at 
positions 146-162 with bm 1, should bear all target structures recognized by B6 
anti-bml  CTL.  However, both  in  direct  lysis  experiments  and  monolayer ad- 
sorption experiments this is clearly not the case. Neither the adsorption onto H- 
2Ld-bearing monolayers nor the adsorption onto monolayers of other H-2 types 
substantially reduced the CTL activity against bm 1 target cells. Therefore,  the 
presence of the  146-162  AA sequence in the  K bml  molecule creates a  unique 
bml  target  determinant  absent from  L d.  In  addition,  B6 anti-bml  CTL  were 
shown to include separate subsets reactive with K k, D k, and H-2  d minus L d, none 
of which  could be adsorbed onto  Ld-bearing  monolayers.  Therefore,  B6 anti- 
bm 1 CTL contain at least four CTL subsets not reactive with L d (Table I). 
These  findings  can  only be explained  by assuming that  the  presence  of the 
146-162 AA sequence in the K bm~ molecule creates conformational determinants 
different from those induced by the same AA sequence in the context of the L d 
molecule. 
This conclusion is further supported by the earlier observation that  B6 anti- 
bml  CTL  cross-reactive  with  several  other  K b mutants  that  do not  share  any 
primary structural homology with the mutated portion of the K bm~ molecule (7). 
Apparently,  these mutations in different parts of the H-2 K b molecule result in 
similar new conformational determinants (4, 7). The identity of the AA sequence 
of the K bm~ molecule from positions 146-162 with the L d molecule, raised doubts 
on point mutation as the mechanism underlying the generation of H-2 mutants. 
As an alternative,  gene conversion  was proposed to explain  this finding.  Gene 
conversion is a  genetic event in which a  particular  gene segment is transferred 
from one homologous gene to another  (8,  9).  The  sharing  of an  AA segment 
between K bm~ and  L d on the basis of gene conversion can be explained in two 
ways. The bml  mutation  originated  in a  (B6 ×  BALB/c)FI mouse where gene 
conversion could have occurred, or, the B6 genome contains an Ld-like pseudo- 
gene which by definition remains normally silent.  In favor of gene conversion is 
the finding that identical complex mutations occurred repeatedly and independ- 
ently  of each  other  and  that  many  mutations  show  clusters  of AA  changes 
TABLE  I 
Distinct CTL Subpopulations  Among B6 Anti-bm l  CTL 
Subset  Specificity  Relevant adsorp-  Reactive 
tion (Fig.)  with L d 
1  bml  unique  2, A-E  - 
2  K k  2  D  - 
3  D k  2  E  - 
4  H-2 d minus L a  2 A  and B  - 
5?  Dq?  2  E  ? 
6  L d  2 B  + DE  WAAL ET AL.  1725 
requiring multiple base substitutions (8, 9,  13).  Gene conversion has also been 
invoked to explain the differences among HLA-B7,  HLA-28, and HLA-A2 in 
the first variable segment (14). 
Our data also correspond with those of Hunt and Sears (15),  whose studies 
indicated that structural homology between two class I molecules is not necessar- 
ily associated with CTL cross-reactivity. For example, in their study b-anti-bm 1 
CTL cross-reacted only partially with La-positive target cells of the H-2  a haplo- 
type, in agreement with our data. 
With  regard  to  the  question  whether MHC-restricted CTL  also  recognize 
conformational determinants, it is striking that bm 1 CTL specific for lymphocytic 
choriomeningitis (LCM) virus, vaccinia virus, and ectromelia virus do not rec- 
ognize virus-infected target cells expressing H-2L  d (16,  17).  Moreover, the bml 
mutant  has  gained  new restriction  specificities unique  for  K bml  in  the  TNP- 
specific CTL  response (de Waal  et ai.,  unpublished observations), whereas H- 
2Ld-restricted TNP-specific CTL responses were not observed (18). Conversely, 
in H-2  a mice the vesicular stomatitis virus (VSV)-specific CTL response is solely 
restricted by H-2L  a (19), whereas bml is a CTL nonresponder against VSV (J. 
Forman, personal communication). These findings can again be explained best 
by assuming that the 146-162 segment in the K  bml molecule creates conforma- 
tional determinants different from those in H-2L  d. 
Taken together, our data strongly strengthen the notion that CTL recognize 
conformational determinants and not primary amino acid sequences.  Further 
insight into the three dimensional structure of MHC antigens is needed to answer 
the question of what T  cells really see. 
Summary 
The bml  H-2K b mutant differs from the parental strain C57BL/6  (B6) only 
at amino acid (AA) positions  152,  155, and 156 of the H-2K molecule. The H- 
2L  a molecule is structurally identical with the H-2 K bml molecule from positions 
146-162,  thus including all three AA substitutions in K  bin1. In direct iysis and 
monolayer adsorption studies, B6 anti-bml cytotoxic T  lymphocytes (CTL) were 
shown to include at least five distinct CTL subsets of the following specificities. 
(a) Uniquely reactive with Kbml; (b) cross-reactive with Kk; (c) cross-reactive with 
Dk; (d) cross-reactive with H-2  d minus L a, and (e) cross-reactive with L d. If B6 
anti-bml CTL were directed against the primary AA-sequence difference, then 
all five subsets are expected to react with L a.  However, four out of five CTL 
subsets including a  major population  uniquely directed against  K  bm~ failed to 
react with L d. 
These findings strongly strengthen the notion that CTL recognize conforma- 
tionai determinants and not primary AA sequences. 
We thankJ, de Hoop for excellent technical assistance and our colleagues at the CLB for 
critically reviewing the manuscript. 
Received  for publication 6July 1983. 
References 
1.  Burakoff, S. J.,  R.  Finberg,  L.  Glimcher,  F.  Lemonnier, B.  Benacerraf, and H. 
Cantor. 1978. The biological significance of alloreactivity..]. Exp. Med. 146:1414. 1726  CYTOTOXIC T  LYMPHOCYTES 
2.  Miillbacher, A., and R. V. Blanden. 1979. Crossreactivity patterns of murine cytotoxic 
T  lymphocytes. Cell. hnmunol.  43:70. 
3.  Taswell, C.,  H.  Robson  MacDonald,  and J.  C.  Cerottini.  1980.  Clonal analysis of 
cytotoxic T-lymphocyte specificity. J. Exp. Med. 151:1372. 
4.  Sherman,  L.  A.  1982.  Recognition  of conformational  determinants  on  H-2  by 
cytolytic T  lymphocytes. Nature (Lond.). 297:511. 
5.  Finberg, R., and B. Benacerraf. 1981.  Induction control and consequences of virus- 
specific cytotoxic T  cells, lmmunol.  Rev. 58:157. 
6.  Zinkernagel,  R.  M.,  and  K.  L.  Rosenthal.  1981.  Experiments and  speculation  on 
antiviral specificity of T  and B cells, hnmunol.  Rev. 58:131. 
7.  Melief, C. J.  M.,  L.  P.  de Waal,  M.  Y.  van der Meulen,  R. W.  Melvold, and H.  I. 
Kohn. 1980. Fine specificity of alloimmune cytotoxic T  lymphocytes directed against 
H-2K.J. Exp. Med.  151:993. 
8.  Pease,  L.  R.,  D.  H.  Schulze,  G.  M.  Pfaffenbach,  and  S.  G.  Nathenson.  1983. 
Spontaneous  H-2  mutants  provide evidence that  a  copy mechanism analogous to 
gene conversion generates polymorphism in  the  MHC. Proc. Natl.  Acad. Sci. USA. 
80:242. 
9.  Weiss,  E.  A.,  A.  Mellor,  L.  Golden,  K.  Fahmer,  E.  Simpson, J.  Hurst,  and  R.  A. 
Flavell.  1983. The structure of a mutant H-2 gene suggests that the generation of 
polymorphism in H-2 genes may occur by gene conversion-like events. Nature (Lond.). 
301:671. 
I0.  Evans, G. A., D. H. Margulies, R. D. Camerini-Otero, K. Ozato, and J. G. Seidman. 
1982.  Structure and expression of a  mouse major histocompatibility antigen gene, 
H-2L  '~. Proc. Natl.  Acad. Sci. USA. 79:1994. 
11.  Moore,  K.  W.,  B.  T.  Shey,  Y.  H.  Sun,  K.  A.  Eakle,  and  L.  Hood.  1982.  DNA 
sequence of a  gene encoding a  BALB/c  mouse L d transplantation  antigen. Science 
(Wash. DC). 215:679. 
12.  Melief, C.J.M., L. P. de Waal, M. Y. van der Meulen, P. Iv~nyi, and R. W. Melvold. 
1981. Fine specificity of cytotoxic T  lymphocytes directed against H-2L  d. Immunoge- 
netics. 12:75. 
13.  Nairn, R., K. Yamaga, and S. G. Nathenson. 1980. Biochemistry of the gene products 
from murine MHC mutants. Annu. Rev. Genet. 14:241. 
14.  L6pes  de  Castro, J.  A., J.  L.  Strominger,  D.  M.  Strong,  and  H.  T.  Orr.  1982. 
Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA- 
A2: possible implications for the generation of HLA polymorphism. Proc. Natl. Acad. 
Sci. USA. 79:3813. 
15.  Hunt, P., and D. W. Sears.  1983. CTL crossreactivities reveal shared immunodomi- 
nant determinants created by structurally homologous regions of MHC class-I anti- 
gens.J, hnmunol.  130:1439. 
16.  Blanden, R. V., M. B. C. Dunlop, P. C. Doherty, H. I. Kohn, and I. F. C. McKenzie. 
1976.  Effects  of  four  H-2K  mutations  on  virus-induced  antigens  recognized  by 
cytotoxic T  cells, hnmunogenetics. 3:541. 
17.  Zinkernagel,  R.  M.  1976.  H-2 compatibility requirements for virus-specific T-cell- 
mediated cytolysis. J. Exp. Med.  143:437. 
18.  Levy, R.  B.,  T.  H.  Hansen,  and  G.  M.  Shearer.  1978.  Properties of H-2L locus 
products in allogeneic and H-2-restricted trinitrophenyl-specific cytotoxic responses. 
J. hnmunot.  121:2263. 
19.  Ciavarro, R., and J. Forman.  1982.  H-2L-restricted recognition of viral antigens. J. 
Exp. Med. 156:778. 